BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11224 related articles for article (PubMed ID: 1383295)

  • 1. Increased epidermal growth factor receptors in melanocytic lesions.
    Ellis DL; King LE; Nanney LB
    J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and distribution of transforming growth factor-alpha within melanocytic lesions.
    Nanney LB; Coffey RJ; Ellis DL
    J Invest Dermatol; 1994 Nov; 103(5):707-14. PubMed ID: 7963661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
    Cockerell CJ; Berson DS
    Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases.
    Ball NJ; Golitz LE
    J Am Acad Dermatol; 1994 May; 30(5 Pt 1):724-9. PubMed ID: 8176011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of eccentric foci of hyperpigmentation ('small dark dots') within melanocytic nevi. Analysis of 59 cases.
    Bolognia JL; Lin A; Shapiro PE
    Arch Dermatol; 1994 Aug; 130(8):1013-7. PubMed ID: 8053697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated squamous intraepithelial lesion (dSIL)-like changes in the epidermis overlying anogenital melanocytic nevi: A diagnostic pitfall.
    Michalova K; Kazakov DV; Michal M; Hadravsky L; Kacerovska D; Rychly B; Miesbauerova M; Michal M
    Ann Diagn Pathol; 2017 Feb; 26():43-46. PubMed ID: 28038710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocytic nevi simulant of melanoma with medicolegal relevance.
    Massi G
    Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; OkoĊ„ K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic classification of the combined nevus. Analysis of the variable expression of melanocytic nevi.
    Pulitzer DR; Martin PC; Cohen AP; Reed RJ
    Am J Surg Pathol; 1991 Dec; 15(12):1111-22. PubMed ID: 1746678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological analysis of intraepidermal proliferations of atypical melanocytes.
    Urso C; Giannini A; Bartolini M; Bondi R
    Am J Dermatopathol; 1990 Apr; 12(2):150-5. PubMed ID: 2331049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 562.